[{"NetIncomeLoss_1_Q2_USD":-133988000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":6000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":32554000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":63334000.0,"AssetsCurrent_0_Q2_USD":564466000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":16798000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-718000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-1673000.0,"ContractWithCustomerLiability_0_Q2_USD":5256000.0,"FinanceLeaseInterestPaymentOnLiability_2_Q2_USD":628000.0,"Depreciation_2_Q2_USD":5242000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-254252000.0,"AccountsPayableRelatedPartiesCurrent_0_Q2_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-4567000.0,"InventoryFinishedGoods_0_Q2_USD":7799000.0,"RepaymentsOfDebtAndCapitalLeaseObligations_2_Q2_USD":201000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":147801000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":900000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3000.0,"PaymentsToAcquireAvailableForSaleSecurities_2_Q2_USD":266647000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9400000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"ContractualObligation_0_Q2_USD":81900000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":97091000.0,"ShareBasedCompensation_2_Q2_USD":38385000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":57000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-68000.0,"Assets_0_Q2_USD":808618000.0,"CommonStockSharesIssued_0_Q2_shares":92609000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":16000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":17000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-38000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":13454000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":14000.0,"FinanceLeaseInterestExpense_1_Q2_USD":242000.0,"FinanceLeaseInterestExpense_2_Q2_USD":627000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":25000000.0,"AvailableForSaleSecurities_0_Q2_USD":259609000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":11400000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"DueFromRelatedPartiesCurrent_0_Q2_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":92276000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":91983000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":301000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":71000.0,"OtherSundryLiabilitiesNoncurrent_0_Q2_USD":2469000.0,"Supplies_0_Q2_USD":5256000.0,"CommonStockValue_0_Q2_USD":926000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-3000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":130000.0,"AccountsReceivableNetCurrent_0_Q2_USD":24266000.0,"PrepaidExpenseCurrent_0_Q2_USD":7149000.0,"MinorityInterest_0_Q2_USD":19271000.0,"ProceedsFromSaleOfAvailableForSaleSecurities_2_Q2_USD":4000000.0,"InventoryRawMaterials_0_Q2_USD":1190000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":125377000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":122567000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":197243000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":7534000.0,"ShortTermInvestments_0_Q2_USD":153851000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":30000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":11756000.0,"OtherAssetsCurrent_0_Q2_USD":1309000.0,"IncreaseDecreaseInInventories_2_Q2_USD":7861000.0,"MoneyMarketFundsAtCarryingValue_0_Q2_USD":220627000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":259534000.0,"OperatingLeaseLiability_0_Q2_USD":104914000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":17000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-38000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-8065000.0,"FinanceLeaseLiability_0_Q2_USD":29000.0,"Liabilities_0_Q2_USD":528767000.0,"Cash_0_Q2_USD":130035000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":10610000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":94196000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":353361000.0,"OtherAssetsNoncurrent_0_Q2_USD":4617000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1013000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-133931000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-205811000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":11000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":147801000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":33078000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":18193000.0,"LiabilitiesCurrent_0_Q2_USD":232764000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":15517000.0,"GainLossOnDispositionOfAssets_2_Q2_USD":-13000.0,"InventoryWorkInProcess_0_Q2_USD":15541000.0,"OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities_1_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities_2_Q2_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-71527000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":40000.0,"AccountsPayableCurrent_0_Q2_USD":48988000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-30000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":38385000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":5928000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_2_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-134553000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-205936000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0455,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":116359000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":19001000.0,"InterestExpense_2_Q2_USD":856000.0,"InterestExpense_1_Q2_USD":355000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8458000.0,"NetIncomeLoss_2_Q2_USD":-205743000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":30670000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":2246000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":279851000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":353361000.0,"AdditionalPaidInCapital_0_Q2_USD":1443975000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":0.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":3066000.0,"SubleaseIncome_1_Q2_USD":275000.0,"SubleaseIncome_2_Q2_USD":575000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0475,"FinanceLeaseRightOfUseAssetAmortization_1_Q2_USD":1777000.0,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":4393000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":5033000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":446000.0,"DeferredTaxAndOtherLiabilitiesNoncurrent_0_Q2_USD":8985000.0,"CommonStockSharesOutstanding_0_Q2_shares":92609000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-17868000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-325032000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":19001000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":38385000.0,"PreferredStockSharesAuthorized_0_Q2_shares":125000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":18047000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":808618000.0,"OperatingLeaseCost_1_Q2_USD":1744000.0,"OperatingLeaseCost_2_Q2_USD":2162000.0,"PreferredStockValue_0_Q2_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":25234000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":146000.0,"AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments_2_Q2_USD":-8000.0,"InventoryNet_0_Q2_USD":24530000.0,"OperatingIncomeLoss_1_Q2_USD":-133835000.0,"OperatingIncomeLoss_2_Q2_USD":-204263000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":24364000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":62793000.0,"CommonStockSharesAuthorized_0_Q2_shares":225000000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-2231000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":861000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":20463000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":147029000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":303000.0,"LeaseCost_1_Q2_USD":3488000.0,"LeaseCost_2_Q2_USD":6607000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1179754000.0,"CommercialPaperAtCarryingValue_0_Q2_USD":2699000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q2_USD":13352000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-767000.0,"LongTermInvestments_0_Q2_USD":105758000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2215000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":152865000.0,"StockholdersEquity_0_Q2_USD":260580000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":23000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":30659000.0,"ProfitLoss_2_Q2_USD":-205743000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.45,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.24,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":3498000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":27745000.0,"OperatingExpenses_1_Q2_USD":158199000.0,"OperatingExpenses_2_Q2_USD":267056000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":10718000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":7471000.0,"Ticker":"FGEN","CIK":"921299","name":"FIBROGEN INC","OfficialName":"FibroGen Inc Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"987680900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]